Sergio C Oliveira Selected Research

Sergio C Oliveira Research Topics

Disease

39	Infections 12/2021 - 08/2002
15	Schistosomiasis (Bilharziasis) 01/2022 - 08/2005
10	Bites and Stings (Sting) 12/2021 - 01/2011
8	Brucellosis (Malta Fever) 12/2020 - 02/2002
7	Bacterial Infections (Bacterial Infection) 12/2021 - 01/2004
6	Inflammation (Inflammations) 12/2021 - 01/2014
4	Asthma (Bronchial Asthma) 09/2020 - 09/2006
4	Reinfection 10/2018 - 11/2008
4	Parasitic Diseases (Parasitic Disease) 01/2018 - 04/2003
3	Neoplasms (Cancer) 01/2021 - 04/2003
3	Schistosomiasis mansoni 01/2017 - 06/2008
2	Arthritis (Polyarthritis) 01/2021 - 01/2018
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2021
2	Splenomegaly 12/2020 - 01/2014
2	COVID-19 11/2020 - 01/2020
2	Hypersensitivity (Allergy) 09/2020 - 01/2013
2	Granuloma 01/2013 - 01/2004
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021
1	Chronic Disease (Chronic Diseases) 12/2020
1	Airway Remodeling 09/2020
1	Lung Diseases (Lung Disease) 09/2020
1	Whooping Cough (Pertussis) 01/2020
1	Communicable Diseases (Infectious Diseases) 10/2018
1	Gout 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Skin Ulcer 01/2018
1	Cutaneous Leishmaniasis 01/2018
1	Enterocolitis 12/2017
1	Colitis 12/2017
1	Wounds and Injuries (Trauma) 12/2017
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2017
1	Thrombosis (Thrombus) 12/2015

Drug/Important Bio-Agent (IBA)

18	VaccinesIBA 11/2020 - 02/2002
13	CytokinesIBA 12/2021 - 04/2003
13	AntigensIBA 01/2018 - 02/2002
9	Proteins (Proteins, Gene)FDA Link 01/2018 - 12/2002
8	InflammasomesIBA 01/2022 - 04/2013
8	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 01/2011
7	Carrier Proteins (Binding Protein)IBA 10/2021 - 01/2018
7	Interleukin-10 (Interleukin 10)IBA 01/2018 - 09/2006
6	Pharmaceutical PreparationsIBA 08/2014 - 11/2008
6	Interleukin-12 (IL 12)IBA 02/2014 - 08/2002
4	InterferonsIBA 12/2021 - 11/2017
3	cyclic guanosine monophosphate-adenosine monophosphateIBA 12/2021 - 01/2018
3	InterleukinsIBA 09/2020 - 08/2002
3	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017 - 10/2008
3	Interferon-gamma (Interferon, gamma)IBA 02/2014 - 08/2002
3	DNA VaccinesIBA 08/2006 - 04/2003
2	Interferon Type IIBA 12/2021 - 01/2011
2	Interleukin-6 (Interleukin 6)IBA 12/2020 - 02/2014
2	Protease Inhibitors (Protease Inhibitor)IBA 10/2018 - 01/2018
2	Praziquantel (Biltricide)FDA Link 10/2018 - 12/2013
2	LigandsIBA 01/2018 - 01/2017
2	Small Interfering RNA (siRNA)IBA 01/2018 - 12/2014
2	EpitopesIBA 01/2017 - 06/2008
2	AntibodiesIBA 01/2017 - 01/2013
2	Type IV Secretion SystemsIBA 01/2017 - 04/2013
2	Recombinant ProteinsIBA 12/2013 - 01/2006
2	Toll-Like Receptor 6IBA 09/2013 - 05/2013
2	Immunoglobulin E (IgE)IBA 01/2013 - 03/2012
2	Combined VaccinesIBA 01/2012 - 01/2011
1	Galectin 3 (LGALS3)IBA 10/2021
1	Hormones (Hormone)IBA 01/2021
1	Uric Acid (Urate)IBA 01/2021
1	Succinic Acid (Succinate)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Nucleic Acid-Based VaccinesIBA 11/2020
1	Interleukin-33IBA 09/2020
1	Complex MixturesIBA 09/2020
1	Ethambutol (Myambutol)FDA LinkGeneric 01/2019
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2019
1	MacrolidesIBA 01/2019
1	Rifabutin (Ansamycin)FDA Link 01/2019
1	GoldIBA 10/2018
1	Pancreatic Elastase (Elastase)IBA 01/2018
1	Pyrin Domain-Containing 3 Protein NLR FamilyIBA 01/2018
1	Acetates (Acetic Acid Esters)FDA Link 01/2018
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 11/2017
1	NocodazoleIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 01/2017
1	NLR ProteinsIBA 01/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2017
1	Pattern Recognition ReceptorsIBA 01/2017
1	Guanylate Cyclase (Guanylyl Cyclase)IBA 12/2016
1	bis(3',5')-cyclic diguanylic acidIBA 12/2016
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 12/2016
1	Immunologic Factors (Immunomodulators)IBA 01/2016
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2015
1	Fibrinolysin FDA Link 12/2015
1	Nucleic AcidsIBA 12/2014
1	Viral RNAIBA 12/2014
1	Viral DNAIBA 12/2014

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 01/2021 - 01/2011
3	Therapeutics 12/2021 - 01/2021
2	Immunotherapy 01/2021 - 04/2003
1	Adjuvant Chemotherapy 01/2021
1	Aftercare (After-Treatment) 10/2018